GGrantIndex
Sort

25,944 grants matching neurodegeneration

Parkin mediated Neural Dysfunction in Drosophila

$252,220
University Of Washington · R01 · FY2001 · NS

a-Synuclein in Transgenic Models of MSA

$252,203
Eliezer Masliah · Mayo Clinic Rochester · P01 · FY2010 · NS

Processing Of Oxidative Stress In Alzheimer

$252,198
Vilhelm A Bohr · National Institute On Aging · ZIA · FY2016 · AG

Potential anti-relapse drugs: a plant genomics approach

$252,137
John M Littleton · Naprogenix, Inc · R42 · FY2008 · AA

Mechanism for Altered Synaptic Function During Aging

$252,064
Thomas C Foster · University Of Florida · R01 · FY2011 · AG

Dynorphin Modulation of N-Methyl-D-Aspartate (NMDA) Receptor Function

$252,011
Robert M Caudle · University Of Florida · R01 · FY2009 · NS

Neuromodulation of brain network function in preclinical and prodromal Alzheimer's Disease

$252,000
Alexandra Touroutoglou · Massachusetts General Hospital · R21 · FY2023 · AG

Boston University Alzheimer's Disease Core Center

$252,000
Neil W. Kowall · Boston University Medical Campus · P30 · FY2009 · AG

Cytohesins, ARF GTP'ases and Neurodegeneration

$252,000
Robert G Kalb · Children'S Hosp Of Philadelphia · R21 · FY2016 · NS

ERAD genes that suppress neurodegeneration

$252,000
Robert G Kalb · Children'S Hosp Of Philadelphia · R21 · FY2014 · NS

Non invasive in vivo imaging of pathological fibrin deposition in the human brain

$252,000
Caterina Mainero · Massachusetts General Hospital · R21 · FY2023 · NS

HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration

$251,869
University Of Miami School Of Medicine · R01 · FY2004 · CA

HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration

$251,869
University Of Miami School Of Medicine · R01 · FY2005 · CA

BTBD9, a novel regulator of manganese-induced neurotoxicity

$251,813
Pandy Chen · Albert Einstein College Of Medicine · R21 · FY2020 · ES

Admin Core

$251,797
Douglas Hamilton Smith · University Of Pennsylvania · U54 · FY2020 · NS

Combination Antiretroviral Therapy and inflammation/neurodegeneration in the CNS

$251,729
M Christine Zink · Johns Hopkins University · P01 · FY2007 · MH

Beclin 1 Neurodegeneration and Alzheimer's Disease

$251,413
Tony Wyss-Coray · Palo Alto Veterans Instit For Research · R01 · FY2012 · AG

Beclin 1 Neurodegeneration and Alzheimer's Disease

$251,413
Tony Wyss-Coray · Palo Alto Veterans Instit For Research · R01 · FY2011 · AG

Toxicant-induced synaptic dysfunction and neurotoxicity in Parkinson disease

$251,410
Kim Tieu · Florida International University · R01 · FY2016 · ES

Neurodegenerative Changes in Post-Stroke Depression

$251,386
Sean I Savitz · University Of Texas Hlth Sci Ctr Houston · R21 · FY2022 · MH

Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)

$251,332
Nigel H. Greig · National Institute On Aging · ZIA · FY2022 · AG

INTEGRINS: LINKING SENILE PLAQUES AND NEURITIC DYSTROPHY

$251,318
Adriana B Ferreira · Northwestern University At Chicago · R01 · FY2006 · NS

Sphingolipid Metabolism and Signaling in the Retina

$251,268
Nawajes Mandal · University Of Tennessee Health Sci Ctr · R01 · FY2016 · EY

Role of Sarm1 in TBI-accentuated C9orf72 Frontotemporal Dementia

$251,250
Nils Henninger · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · NS

Does TDP-43 dysfunction in astrocytes trigger motor neuron degeneration?

$251,250
Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R21 · FY2016 · NS